Use of Play Dough in Children Receiving Nebulizer Therapy

Sponsor
Maltepe University (Other)
Overall Status
Completed
CT.gov ID
NCT05779826
Collaborator
(none)
80
1
2
4.9
16.3

Study Details

Study Description

Brief Summary

The aim of this study is to present the results of the effect of playing with play dough on treatment compliance in children aged 3-6 years receiving nebulizer therapy. In the randomized controlled study, 80 children who were hospitalized in the pediatric ward of a public hospital and met the inclusion criteria were equally divided into 2 groups. Play dough was played while receiving nebulizer therapy for the children in group 1 (research group). Play dough was not used for the children in the 2nd group. The compliance of the children in the two groups to the treatment was evaluated with the Child's Adherence to Nebulizer Treatment Evaluation Form (CANTEF).

Condition or Disease Intervention/Treatment Phase
  • Device: Play dough
N/A

Detailed Description

Mask use is generally preferred in children receiving nebulizer therapy. Wearing a mask and the noise made by the nebulizer device cause fear and stress in the child, leading to maladaptive behaviors such as crying, shouting, and trying to remove the mask. The aim of this study is to distract the child who receives nebulizer treatment by playing play dough and to present the results regarding compliance with the treatment.

Methods: This study was conducted in a single-center randomized controlled design. The sample size of the study was calculated in the program of G*Power 3.1.9.2 (Heinrich Heine University Düsseldorf, Germany). The sample size was found to be 35 children for each group. The research was conducted with a total of 80 children. There were 40 children in each group (research and control group). This study was carried out in the pediatric service of a public hospital in Istanbul between October 2021 and February 2022.

Procedures: The participants were divided into groups, the area to be played with play dough was prepared, vital signs were collected, data were collected with CANTEF and all recordings were made by the 1st researcher. She has 3 years of experience as a first research nurse.

In this study, the following procedure was applied respectively. Parents of children aged 3-6 years who are hospitalized in the pediatric service and who will be treated with nebulizers and who meet the sampling criteria will be informed about the study, and verbal and written consent will be obtained. A face-to-face interview method will be used to determine the socio-demographic and clinical characteristics of the children in data collection, and the data will be recorded in the Sick Child Diagnosis Form (SCDF) by the researcher. In order to evaluate the compliance of the children to the nebulizer treatment, the vital signs and behaviors will be evaluated by the researcher and the data will be recorded in the Child's Adherence to the Nebulizer Treatment Evaluation Form. For the random assignment of children to groups, children with an odd number of patient protocol numbers will form the research group, and children with an even number will form the control group. For example, the child with the protocol number 278861 was included in the research group, and the child with the protocol number 236724 was included in the control group. In this study, all evaluations were made in the same way for the children in the research and control groups. SCDF was filled in by obtaining information from the mother or father in the research group. 5 minutes before the nebulizer treatment, an area was created to play with play dough, the child was brought to a sitting position, vital signs were taken, his behavior was evaluated and recorded in the CANTEF. Nebulizer treatment was started at the beginning of the treatment (0. min), vital signs and behaviors were evaluated and recorded in the CANTEF, 5 minutes after the beginning of the treatment, vital signs and behaviors were evaluated and recorded in the CANTEF, 10 minutes after the start of the treatment, vital signs and behaviors were evaluated and recorded in the CANTEF, at the end of the treatment (15. min), the nebulizer treatment was terminated, the game activity was finished, and the behaviors were evaluated and recorded in the CANTEF. In the control group, the same procedures were performed in the same way without playing the play dough.

Instruments: Data were collected with the Sick Child Diagnosis Form (CSDFF) and the Child's Adherence to Nebulizer Treatment Evaluation Form (CANTEF). The forms were developed by the researchers based on the literature. The Sick Child Diagnosis Form (SCDF) is prepared for the child's age, gender, nationality, school attendance, whether he or she has been given nebulizer treatment before, if so, his reactions, reason for applying to the emergency department, diagnosis, whether he has a chronic disease, behavioral disorder such as attention deficit and hyperactivity disorder or not. It is a form consisting of 11 questions, which includes information about whether there is a diagnosed disease for respiratory diseases and whether there is a drug that he constantly uses if these diseases exist. While the first four questions determine the socio-demographic data of the child, the other seven questions describe the clinical features. Child's Adherence to Nebulizer Treatment Evaluation Form was prepared by the researcher and consultant to evaluate the vital signs and behaviors of children 5 minutes before the treatment, at the beginning of the treatment, 5 minutes after the start of the treatment, 10 minutes after the start of the treatment, and at the end of the treatment. In the evaluation of vital signs, there are 5 criteria: radial pulse, temporal fever, respiratory rate, respiratory function and SPO2. There are 10 behavioral criteria in the evaluation section of the child's behavior. For each behavioral criterion, there are two options, "yes" and "no". The 9th behavioral criterion will be evaluated from the beginning of the treatment (0. min). The 10th behavioral criterion will be evaluated only for the children in the research group. In the study, console type pulse oximeter, temporal thermometer and surgical mask were used in the research and control groups. In the research group, play dough was used during the treatment of children receiving nebulizer therapy.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Playing Dough on Children's Adaptation to Nebulizer Treatment Children 3-6 Years Old Child Service: Randomized Controlled Study
Actual Study Start Date :
Oct 1, 2021
Actual Primary Completion Date :
Feb 15, 2022
Actual Study Completion Date :
Feb 27, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Research Group

Play dough was played while receiving nebulizer therapy for the children in research group.

Device: Play dough
In the research group, play dough was used during the treatment of children receiving nebulizer therapy.

No Intervention: Control Group

Play dough was not used for the children in the control group.

Outcome Measures

Primary Outcome Measures

  1. Identifying the child's adherence with nebulizer therapy [Change in child's behavior with in 15 minutes during nebulizer therapy]

    The child's behavior during nebulizer therapy was evaluated using the Child's Adherence to Nebulizer Treatment Evaluation Form.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 6 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Parent's consent to participate in the study

  • Stable clinical status

  • The child's motor skills should be at a level to be able to play with play dough and should be developed according to his age,

  • The child's ability to speak and understand Turkish.

Exclusion Criteria:
  • Any physical or mental disability that prevents the child from playing with play dough

  • The child has a behavior disorder or disease that causes maladaptive behavior

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maltepe University Istanbul Maltepe Turkey

Sponsors and Collaborators

  • Maltepe University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Behice Ekici, Assistant Professor, PhD, Maltepe University
ClinicalTrials.gov Identifier:
NCT05779826
Other Study ID Numbers:
  • 2023/02-23
First Posted:
Mar 22, 2023
Last Update Posted:
Mar 22, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Behice Ekici, Assistant Professor, PhD, Maltepe University

Study Results

No Results Posted as of Mar 22, 2023